Under normal circumstances, a healthy human ovary would develop one follicle every month. However for every follicle formed each month many others are wasted due to the "dominant" follicle "cutting off" the others. In some women with conditions such as polycystic ovary syndrome or hypothalamic amenorrhea, regular follicle development and ovulation does not occur.
The goal of ovulation induction is to restore natural process of ovulation by the least aggressive and costly drugs when feasible. Sometimes ovulation induction can result in the growth of more than one follicle because it reduces the competition between those follicles for the "top" spot. This maybe beneficial in some cases where the egg reserve or quality is low but in other cases not desirable as it may increase the risk of multiple pregnancies (such as twins and triplets or higher).
At the Institute for Reproductive Medicine we have extensive experience with ovulation induction treatments beyond the ordinary treatments offered. These include tamoxifen and aromatase inhibitors which may offer several advantages based on Dr. Oktay's and others research studies.